FDA Clears AI-Powered Software for Lung Nodule Detection on Chest CT
The F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced CT workflow and automated reporting for evaluation of lung nodules
The Food and Drug Administration (FDA) has granted 510(k) clearance for the F.A.S.T. aiCockpit CT Lung Nodule, which may bolster workflow efficiencies with interpretation of chest computed tomography (CT) scans.
Available for two-dimensional (2D) and three-dimensional (3D) CT exams, the F.A.S.T. aiCockpit CT Lung Nodule facilitates efficient descriptions and measurements of lung nodules, and rejection of false positives, according to Fovia Ai, the developer of the software.
The newly FDA-cleared F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced workflows and reporting with assessment of lung nodules on chest CT scans. (Image courtesy of Fovia.Ai. (Image courtesy of Fovia.Ai.)
Once radiologists have completed their assessment and review of the findings, Fovia Ai said the F.A.S.T. aiCockpit CT Lung Nodule automatically forwards the final results for inclusion in the radiology report.
The company noted that the F.A.S.T. aiCockpit CT Lung Nodule allows for easy integration into existing PACS systems, universal viewers, and other AI platforms.
Emphasizing that the F.A.S.T. aiCockpit CT Lung Nodule is the initial component of the F.A.S.T. aiCockpit Universal AI Viewer, which will reportedly offer a variety of AI algorithms for radiology, according to Fovia.Ai.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
